Normal Saline: Clinical Trials

1,912 trials of Normal Saline, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1070 completed, 365 unknown, 147 terminated, 99 recruiting. 557 Not applicable, 463 Phase 4, 438 Phase 2, 328 Phase 3, 217 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable557Completed 317, Unknown 123, Not yet recruiting 29, Terminated 26, Recruiting 22, Withdrawn 21, Active not recruiting 10, Suspended 5, Enrolling by invitation 4
Phase 4463Completed 250, Unknown 106, Terminated 31, Not yet recruiting 25, Withdrawn 22, Recruiting 16, Active not recruiting 9, Enrolling by invitation 2, Suspended 2
Phase 2438Completed 239, Unknown 66, Terminated 49, Recruiting 29, Withdrawn 26, Active not recruiting 13, Not yet recruiting 12, Enrolling by invitation 2, Suspended 2
Phase 3328Completed 184, Unknown 52, Terminated 31, Recruiting 23, Withdrawn 16, Active not recruiting 11, Not yet recruiting 9, Suspended 2
Phase 1217Completed 131, Unknown 34, Terminated 19, Recruiting 13, Withdrawn 8, Not yet recruiting 7, Active not recruiting 5
Early Phase 155Completed 25, Unknown 14, Terminated 7, Recruiting 4, Withdrawn 3, Not yet recruiting 1, Suspended 1

Follow Normal Saline: new trials by email Literature Review of Normal Saline trials Research Report on Normal Saline

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ketamine and Midazolam Infusions for CRPS: Feasibility Study
Ketamine, Midazolam, Normal Saline - Complex Regional Pain Syndromes
Phase 2WithdrawnStanford University2099-01-012024-11-22
A Study to Determine the Safety and Efficacy of TG-C in Subjects With Symptomatic Early Hip Osteoarthritis
TG-C, Placebo Control - Degenerative Osteoarthritis
Phase 2Not yet recruitingKolon TissueGene, Inc.2552027-10-012026-08-20
GV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD)
GV1001 Placebo, GV1001 1.12mg - Moderate to Severe Alzheimer's Disease
Phase 3Not yet recruitingSamsung Pharmaceutical Co., Ltd.7502027-07-012026-06-10
Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in Patients With ARDS
Normal Saline, Centhaquine - Acute Respiratory Distress Syndrome (ARDS)
Phase 2Not yet recruitingPharmazz, Inc.802027-05-012026-09-17
Challenge Trial of PfSPZ-LARC2 Vaccine in Burkina Faso
PfSPZ-LARC2 Vaccine, PfSPZ Challenge, Normal Saline - Malaria (Plasmodium Falciparum)
Phase 1Not yet recruitingSanaria Inc.452027-03-012026-07-31
A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent
Normal Saline, Centhaquine - Hypovolemic Shock
Phase 3Not yet recruitingPharmazz, Inc.4302027-02-012026-09-17
Umbilical Cord-derived Mesenchymal Stem Cell Injectables for the Regeneration of Partial-thickness Rotator Cuff Tears
umbilical cord-derived mesenchymal stem cell, Normal Saline - Rotator Cuff Disease
Not applicableNot yet recruitingKyoung Hwan Koh382027-02-012026-11-09
A Phase 1 Clinical Trial of Adjuvanted Protein-based HCV Vaccine Candidates (HCV Vaccine Trial)
AVIHepC1, Normal Saline - Hepatitis C
Phase 1Not yet recruitingUniversity of Alberta272027-01-152026-09-25
Nebulised Colistimethate Sodium to Prevent Pediatric Ventilator-associated Pneumonia
colistimethate sodium, 0.9% Saline - Ventilator Associated Pneumonia
Phase 2 / Phase 3Not yet recruitingUniversity Hospital Fattouma Bourguiba4002027-01-012026-10-08
Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage
Normal Saline, Nicardipine - Subarachnoid Hemorrhage
Phase 4Not yet recruitingWake Forest University Health Sciences2142027-01-012026-10-01
Induced Suppression of Platelet Activity in Aneurysmal Subarachnoid Hemorrhage Management-2 (iSPASM-2)
Tirofiban, Placebo - Aneurysmal Subarachnoid Hemorrhage
Phase 1 / Phase 2Not yet recruitingDr David Hasan, M.D.822026-12-052026-11-04
The Effects of Timolol On Healing and Cosmesis of Mohs Scalp Wounds: An Open Label Trial
Topical Timolol, Normal Saline - Surgical Wounds, Mohs Surgery
Phase 2Not yet recruitingGeisinger Clinic452026-12-012026-10-14
Effect of Midazolam Given at Induction on Recall of Propofol Injection Pain
Midazolam, Lidocaine Hydrochloride 2%, Propofol 1% - Propofol Injection Pain, Postoperative Recall of Pain
Phase 4Not yet recruitingAtlas University1502026-12-012026-11-03
Phase 2 Evaluation of Recombinant Human Platelet-Derived Growth Factor-BB (rhPDGF-BB) Injection for the Treatment of Infraorbital Hollowing
RhPDGF-BB, Normal Saline - Infra-orbital Hollows, Skin Quality Improvement
Phase 2Not yet recruitingLynch Regenerative Medicine752026-11-092026-11-04
Impact of Intravenous Dexamethasone on the Duration of Motor and Sensory Block Following Spinal Anesthesia With Chloroprocaine
Intravenous Dexamethasone, Normal Saline - Spinal Anesthesia, Prolonged Sensory Block
Not applicableNot yet recruitingCentre hospitalier de l'Université de Montréal (CHUM)602026-11-012026-10-08
Intravenous Acetate as an Adjunctive Treatment for Alcohol Withdrawal in Hospitalized Patients
Sodium Acetate, Placebo - Alcohol Withdrawal, Alcohol Abstinence
Phase 1 / Phase 2Not yet recruitingUniversity of Colorado, Denver752026-11-012026-10-30
Esketamine Combined With Transcutaneous Electrical Acupoint Stimulation on Postoperative Recovery Quality After Elective Cesarean Section
Esketamine, Active TEAS, Normal Saline - Cesarean Section (MeSH: D002585), Postoperative Pain After Cesarean Section
Not applicableNot yet recruitingAnhui Provincial Hospital3842026-10-302026-11-04
Microneedling-Assisted Metformin, Tranexamic Acid, and Modified Kligman's Formula for Melasma
Metformin 30% Topical Lotion, Tranexamic Acid 0.5% Topical Solution, Modified Kligman's Formula - Melasma (Facial Melasma)
Phase 4Enrolling by invitationSameh Sarsik802026-10-252026-10-27
Ketadex Versus Ketofol for Adult Procedural Sedation in the Emergency Department.
Ketamine (1 mg/kg), propofol, Dexmedetomidine - Procedural Sedation
Phase 4Not yet recruitingSultan Qaboos University1002026-10-102026-10-15
Intraosseous Tranexamic Acid for Reducing Blood Loss in Total Knee Arthroplasty
Tranexamic Acid, Normal Saline - Knee Osteoarthritis
Phase 4Not yet recruitingThe Second Affiliated Hospital of Kunming Medical University702026-10-012026-10-09

Showing 20 of 1912. Sign in to see all of them.

Conditions studied

Pain, Postoperative (107)  ·  Pain (95)  ·  Agnosia (45)  ·  Emergence Delirium (39)  ·  COVID-19 (34)  ·  Sepsis (34)  ·  Acute Kidney Injury (33)  ·  Osteoarthritis (28)  ·  Shock, Septic (28)  ·  Hemorrhage (27)  ·  Postoperative Nausea and Vomiting (24)  ·  Premature Birth (23)  ·  Breast Neoplasms (20)  ·  Malaria (20)  ·  Osteoarthritis, Knee (19)

Sponsors

Assiut University (45)  ·  Seoul National University Hospital (33)  ·  Peking University First Hospital (32)  ·  Yonsei University (30)  ·  Ain Shams University (23)  ·  Allergan (22)  ·  Cairo University (22)  ·  Tanta University (20)  ·  Mayo Clinic (15)  ·  General Hospital of Ningxia Medical University (14)  ·  Johns Hopkins University (14)  ·  Northwestern University (14)  ·  Sanaria Inc. (14)  ·  Tianjin Medical University General Hospital (14)  ·  Chang Gung Memorial Hospital (13)

Countries

United States (619)  ·  China (253)  ·  South Korea (163)  ·  Egypt (159)  ·  Canada (142)  ·  Taiwan (60)  ·  United Kingdom (48)  ·  Australia (41)  ·  Thailand (36)  ·  Pakistan (27)  ·  Germany (26)  ·  Turkey (Türkiye) (26)  ·  France (23)  ·  Denmark (20)  ·  Saudi Arabia (20)

Top investigators

Dong-Xin Wang, MD, PhD (25)  ·  Omar Soliman, MD (6)  ·  Yung-Tsan Wu, MD (6)  ·  Dong-Xin Wang, MD,PhD (5)  ·  Guolin Wang (5)  ·  Guolin Wang, MD (5)  ·  Patrick E Duffy, M.D. (5)  ·  Michael W Donnino, MD (4)  ·  Xiaochun Zheng, MD (4)  ·  Hemant Misra, PhD (3)  ·  Jian-Xin Zhou, MD (3)  ·  Moon Jong Noh, PhD (3)

Results publications

PMID 39428602, PMID 37870112, PMID 39301879, PMID 16275600, PMID 18809959, PMID 19478674, PMID 21300053, PMID 21623291, PMID 21675055, PMID 22939099, PMID 23741350, PMID 24052307, PMID 24754838, PMID 25184864, PMID 25932413, PMID 26220293, PMID 26231052, PMID 26305798, PMID 26807124, PMID 27488394, PMID 28183547, PMID 28279391, PMID 28302179, PMID 28369198, PMID 28778254, PMID 29253090, PMID 29485925, PMID 29784145, PMID 30116551, PMID 30339737, PMID 32665528, PMID 33196806, PMID 34002866, PMID 34473343, PMID 34704710, PMID 34887657, PMID 35443809, PMID 37302963, PMID 38743692, PMID 38987318, PMID 39153490, PMID 40337980, PMID 10077078, PMID 10214567, PMID 10227938, PMID 10231466, PMID 10365009, PMID 10433490, PMID 10484524, PMID 10502118

NIH funding

2014 (7), 2015 (5), 2017 (4), 2016 (3), 2023 (3), 2019 (2), 2025 (2), K23DA029609 (2), U01HL077863 (2), 1UG3HL147011-01A1 (1), 2008 (1), 2009 (1), 5KL2TR002379 (1), 5KL2TR002379-08 (1), K23AR079044 (1)